DBV TECHNOLOGIES
0.000093
EUR
(-1.06%)
03/24/2025 - 11:10
Open 15 min delayed data - Euronext Paris
| Open: | 0.000094 |
| Change: | -0.000001 |
| Volume: | 321 |
| Low: | 0.000092 |
| High: | 0.000096 |
| High / Low range: | 0.000004 |
| Type: | Stocks |
| Ticker: | DBV |
| ISIN: | FR0010417345 |
DBV TECHNOLOGIES news, videos and press releases
For more news please use our advanced search feature.
DBV TECHNOLOGIES - More news...
DBV TECHNOLOGIES - More news...
- 4 H and 42 min ago DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
- 02/25/2025 - 21:01 DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress
- 01/13/2025 - 21:05 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
- 01/08/2025 - 21:05 DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
- 11/11/2024 - 21:30 DBV Technologies Announces Plan to Implement ADS Ratio Change
- 10/18/2024 - 20:30 DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
- 09/04/2024 - 20:30 DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
- 08/02/2024 - 20:30 Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024
- 07/29/2024 - 05:30 DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024
- 07/08/2024 - 20:30 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
- 06/04/2024 - 20:30 Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024
- 05/30/2024 - 20:30 DBV Technologies to Participate in Upcoming EAACI 2024 Congress
- 05/09/2024 - 20:30 DBV Technologies to Participate in Upcoming Investor Conferences
- 04/04/2024 - 20:43 Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024
- 03/08/2024 - 14:33 DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
- 03/07/2024 - 21:30 DBV Technologies Reports Full Year 2023 Financial Results and Business Update
- 02/20/2024 - 21:30 DBV Technologies to Participate in Upcoming AAAAI 2024 Congress
- 01/16/2024 - 21:30 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
- 11/06/2023 - 21:30 Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
- 11/02/2023 - 20:30 DBV Technologies to Present New Data at ACAAI 2023
- 10/27/2023 - 20:30 DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
- 10/05/2023 - 20:30 Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023
- 09/05/2023 - 20:30 DBV Technologies to Participate in Upcoming Investor Conference
- 07/31/2023 - 20:25 DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results
- 07/19/2023 - 20:30 Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023
- 07/10/2023 - 20:30 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
- 06/16/2023 - 13:31 Thinking about buying stock in Applied UV, CBAK Energy Technology, Novavax, C3.ai, or DBV Technologies?
- 06/08/2023 - 20:30 DBV Technologies to Participate in Upcoming EAACI Congress 2023
- 06/06/2023 - 21:00 DBV Technologies to Participate in Upcoming Investor Conference
- 05/09/2023 - 20:30 DBV Technologies to Participate in Upcoming Investor Conference
